Reply to letter: "Tumor regression after neoadjuvant chemotherapy in gastric carcinoma: are there really so few responders?"

Affiliations

¹ Institute of Pathology University of Bern Murtenstr. 31 CH 3010 Bern rupert.langer@pathology.unibe.ch Department of Surgery, Klinikum Rechts der Isar, Technische Universität München Munich, Germany Institute of Pathology, Technische Universität München Munich, Germany.

Free article

Comment

Rupert Langer et al. Ann Surg. 2014 Feb.

Free article

. 2014 Feb;259(2):e30.

doi: 10.1097/SLA.0000000000000280.

¹ Institute of Pathology University of Bern Murtenstr. 31 CH 3010 Bern rupert.langer@pathology.unibe.ch Department of Surgery, Klinikum Rechts der Isar, Technische Universität München Munich, Germany Institute of Pathology, Technische Universität München Munich, Germany.

No abstract available

Comment on

Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Becker K, Langer R, Reim D, Novotny A, Meyer zum Buschenfelde C, Engel J, Friess H, Hofler H. Becker K, et al. Ann Surg. 2011 May;253(5):934-9. doi: 10.1097/SLA.0b013e318216f449. Ann Surg. 2011. PMID: 21490451
Tumor regression after neoadjuvant chemotherapy in gastric carcinoma: are there really so few responders?
Rausei S, Frattini F, Dionigi G. Rausei S, et al. Ann Surg. 2014 Feb;259(2):e29. doi: 10.1097/SLA.0000000000000279. Ann Surg. 2014. PMID: 24096746 No abstract available.